Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-17

Clinical Trial Update: Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms [Phase 4]

View source ↗

Summary

A Phase 4 trial compares digital therapy, trazodone, and daridorexant for menopause-related insomnia in menopausal women and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Daridorexant (daridorexant)
  • Digital therapy
  • Trazodone (trazodone)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Menopausal Women, Insomnia | Phase 4 | Status: RECRUITING